Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012

Details for Mechanism ID: 13356
Country/Region: Kenya
Year: 2011
Main Partner: KNCV Tuberculosis Foundation
Main Partner Program: NA
Organizational Type: Multi-lateral Agency
Funding Agency: USAID
Total Funding: $2,370,000

Narrative:

Kenya is ranked 13th amongst the 22 high burden countries in the world and notified 116,723 TB cases in 2007. This is mainly attributed to the devastating HIV epidemic and an improvement in case detection rate.The TB strategy and HIV care and prevention services are tightly linked to each other. Kenya has made good progress and currently does HIV tests on 80% of all TB patients. 48% of those tested are found to be HIV positive and of those positive 80% are put on cotrimoxazole and 25-30% receive ARV in the first three months of TB treatment. Kenya has also met the WHO global targets for case detection rate and treatment success rates.

Challenges remain and some of these are as follows: a weak monitoring and evaluation system; poor coordination of the various donors and implementing partners working not only on TB but on TB/HIV issues; need to improve TB screening of PLWHA visiting ART, PMTCT and VCT sites; low ART uptake amongst TB patients partly due to the reporting system not been able to capture patients whose treatment is delayed; and weak coordination and collaboration between NASCOP and the TB program.

USAID will utilize the centrally awarded Tuberculosis Control Assistance Program (TBCAP) implemented by KNCV Tuberculosis foundation as the prime and six other organizations as subs including American Thoracic Society, Family Health International, the International Union Against Tuberculosis and Lung Disease, Japanese Anti-Tuberculosis Association, Management Sciences for Health, World Health Organization. The focus of TBCAP is to decrease TB morbidity and mortality in USAID priority TB countries through improving case detection and treatment success.

In Kenya TBCAP will work to improve coordination of firstly USG partners working in TB/HIV helping to clarify the roles of all the various partners particularly as they relate to the overall National TB strategic plan. TBCAP plans to utilize a management tool (Management and Organizational Sustainability Tool MOST) for TBHIV to work with participants form TB and HIV/AIDS programs to determine their status in different collaboration components, prioritize the components for improvement and create and action plan for increased joint activities that will provide an integrated package of services to patients with TB and/or HIV/AIDS. Therefore with this tool the program will be able to analyze the current support and gaps and plan appropriately for further scaling up of TB/HIV. In addition and in order to reach the NGO, CSO and FBO sectors TBCAP will work with the Kenya AIDS NGOs Consortium (KANCO) to address TB HIV amongst their members. KANCO will provide training to CSOs to conduct regular outreach support promoting the TB HIV components.

3. CONTRIBUTIONS TO OVERALL PROGRAM AREA.

This TBCAP activity will contribute to enhancing referrals and linkages between TB and HIV programs, improving monitoring and evaluation of the TB/HIV program and enhancing collaboration of the various development partners and implementing agencies working in TB and TB/HIV. Because the program works nationally no direct targets will be assigned.

4. LINKS TO OTHER ACTIVITIES

The activity will link to all HVTB activities among all USG agencies.

5. POPULATIONS BEING TARGETED

This activity targets People Living with HIV/AIDS, HIV/AIDS affected families and individuals diagnosed with TB.

6. EMPHASIS AREAS

This activity has two major emphasis areas one on networks/linkages/referral systems and the other on supportive supervision, development of referral systems, IEC, and linkages with other sectors and initiatives.

Funding for Care: TB/HIV (HVTB): $2,370,000

None

Key Issues Identified in Mechanism
Tuberculosis